Le Lézard
Classified in: Business
Subject: ATY

Lifshitz & Miller LLP Announces Investigation of Acadia Pharmaceuticals Inc., Allegiant Travel Company, Camping World Holdings, Inc., Finish Line, Inc., Myriad Genetics, Inc., Proteostasis Therapeutics, Inc., Under Armour, Inc. and United Community Bancorp


NEW YORK, April 24, 2018 /PRNewswire/ -- 

Acadia Pharmaceuticals Inc. (ACAD)

Lifshitz & Miller announces investigation into possible securities law violations in connection with a report that Acadia's drug Nuplazid has been associated with more than 700 deaths.

If you are an Acadia investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Allegiant Travel Company (ALGT)

Lifshitz & Miller announces investigation into possible securities law violations in connection with aircraft safety issues and mechanical problems.

If you are an Allegiant investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Camping World Holdings, Inc. (CWH)

Lifshitz & Miller announces investigation into possible securities law violations in connection with allegations of material weaknesses in its internal controls over financial reporting.

If you are a Camping World investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Finish Line, Inc. (FINL)

Lifshitz & Miller announces investigation into possible possible breaches of fiduciary duties in connection with the proposed sale of Finish Line to JD Sports Fashion PLC., for $13.50 in cash per share.

If you are a Finish Line investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Myriad Genetics, Inc. (MYGN)

Lifshitz & Miller announces investigation into possible securities law violations in connection with MYGN's receipt of a subpoena from DHHS regarding possible improper Medicare/Medicaid claims.

If you are a Myriad investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Proteostasis Therapeutics, Inc. (PTI)

Lifshitz & Miller announces investigation into possible securities law violations in connection with PTI's statements regarding PTI-428 trials.

If you are a PTI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Under Armour, Inc. (UA)

Lifshitz & Miller announces investigation into possible securities law violations in connection with a data breach affecting millions of users of UA's app, MyFitnessPal.

If you are an Under Armour investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

United Community Bancorp (UCBA)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of UCBA to Civista Bancshares, Inc., for $2.54 in cash and 1.027 Civista shares per share.

If you are a UCBA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2018 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

SOURCE Lifshitz & Miller Law Firm


These press releases may also interest you

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") and certain officers. The class action, filed in the United States District Court for the Southern District of...

at 11:00
The Georgia Trust for Historic Preservation presented 26 awards recognizing the best of preservation in Georgia during its 47th annual Preservation Awards ceremony in Athens, Ga. Security Federal Bank in Augusta received the Marguerite Williams...

at 11:00
Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against VinFast Auto Ltd. ("VinFast" or the "Company") f/k/a Black Spade Acquisition Co., ("Black Spade") and certain officers. The class action, filed in the United States District...

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ("Ocugen" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext....

at 11:00
Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") and certain officers.  The class action, filed in the United States District Court for the Southern District of...



News published on and distributed by: